全球血栓切除设备市场 – 行业趋势及 2030 年预测

血栓切除设备市场分析和规模

根据世界卫生组织的记录，慢性病是全球死亡和残疾的主要原因。血栓切除术设备在替代终点方面具有许多优势，例如梗塞面积减少、生物标志物分析、ST 段消退和心肌梗死 (TIMI) 血流中的血管造影血栓溶解。预计在预测期内，对微创外科手术的需求增加以及对神经血管和心血管手术的优惠报销政策将推动对机械血栓切除术设备的需求。

Data Bridge Market Research 分析，血栓切除设备市场规模在 2022 年为 13 亿美元，到 2030 年将飙升至 20.6 亿美元，预计在 2023 年至 2030 年的预测期内复合年增长率为 5.9%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

血栓切除设备市场范围和细分

Market Definition

Thrombectomy devices are used for the treatment of pulmonary embolism and peripheral arterial diseases. Currently, they are widely accessible in numerous sizes and diameters, depending on the affected area. Some of the most regularly used thrombectomy devices procedures are surgical embolectomy, balloon embolectomy, and aspiration embolectomy.

Thrombectomy Devices Market Dynamics

Drivers

• Huge rate of Cardiac Cases

There has been increasing cases of cardiac patients that are boosting the growth of the market. For instance, in 2022,the Centre for Disease Control and Prevention (CDC) stated that 805,000 people had a heart attack in the U.S. Out of this, 605,000 are first heart attack patients and 200,000 happen to people who had a heart attack before. As per the records of an article published in the National Library of Medicine, 2022, it stated that in the U.S., around 610,000 people die of heart disease each year. Coronary heart disease is the top cause of death in the Western world killing over 370,000 people yearly. This boosts the market growth.

• Increasing Launch of New Devices

The advancement and launch of new devices such as clot retrievers, suction devices, and aspiration catheters based on advanced technology for ischemic stroke are driving the market growth. For instance, in 2021 Phenox GmbH launched pRESET 6-50 mechanically thrombectomy devices worldwide to surge its technology for acute ischemic stroke. This product has the longest stent retriever in the phenoxy product portfolio. NeuroVasv announced in 2021 that the ENVI-SR Mechanical Thrombectomy System (ENVI-SR) which is a stent-retriever is being launched by NeuroVasc Technologies for the removal of blood clots in patients who are suffering from acute ischemic stroke because of large vessel occlusion.

Opportunities

• Augmented Acquisitions by Several Organizations

There have been several acquisitions by multiple organizations and market players that is expanding the market growth. For instance, in July 2021, Surmodics, which is a leading provider of in vitro diagnostic technologies and medical devices, announced the acquisition of privately held Vetex Medical Limited. The Galway an Ireland-based medical device developer and manufacturer has focused completely on venous clot removal solutions. The transaction expands Surmodics’ thrombectomy portfolio with a second USFDA 510(k)-cleared device, the ReVene Thrombectomy Catheter. The ReVene mechanical thrombectomy catheter is precisely designed to remove large, mixed-morphology blood clots usually found with venous thromboembolism (VTE).

Restraints/Challenges

• High cost of thrombectomy devices

The high cost of thrombectomy devices, and the high risk of infection are expected to hamper the market expansion, due to price fluctuations and a scarcity of experienced experts. Furthermore, patient compatibility and other difficulties, the materials utilised to produce thrombectomy devices are not rapidly approved by several government authorities. The material that is used to make these implants is anticipated to be biocompatible and highly inert. Consequently, finding permission for these devices is tough for businesses.

This thrombectomy devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the thrombectomy devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Thrombectomy Devices Market

The beginning of the COVID-19 pandemic has led to an increase in patients suffering from chronic diseases. This pandemic's effects on patients' health have increased huge cases of respiratory failures leading to deaths. At the beginning of the pandemic, a major decline in the use of mechanical thrombectomy was witnessed globally. Moreover, delay in treatments using mechanical thrombectomy because of infection control measures has as well negatively impacted the market. Although COVID-19 has disturbed numerous healthcare actions, the thrombectomy devices market continued to witness robust growth.

Recent Developments

• In 2022, Cernuous, part of Johnson & Johnson Medical Devices Companies, launched EMBOGUARD. It is a next-generation balloon guide catheter to be used in endovascular procedures in patients with acute ischemic stroke.
• In 2021, Penumbra Inc. announced that the CHEETAH clinical study of its Indigo System CA RX Catheter positively, which had met the primary endpoint,  confirmed high rates of blood flow restoration, blood clot removal, and myocardial perfusion along with percutaneous coronary intervention (PCI) in patients having high thrombus burden.

Thrombectomy Devices Market Scope

The thrombectomy devices market is segmented on the basis of product type, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Aspiration Thrombectomy Devices
• Ultrasonic Thrombectomy Devices
• Mechanical Thrombectomy Devices
• Others

Application

• Cardiovascular Thrombectomy
• Neurovascular Thrombectomy
• Peripheral Vascular Thrombectomy

End-user

• Hospitals
• Ambulatory Surgical Centers

Thrombectomy Devices Market Regional Analysis/Insights

The thrombectomy devices market is analyzed and market size insights and trends are provided by product type, application and end-user as referenced above.

The countries covered in the thrombectomy devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the thrombectomy devices market due to the pervasiveness of numerous pharmaceuticals and biotechnology companies while high pace in technology and rising geriatric population will increase region market growth.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 because of increasing number of geriatric population and rise in disposable income.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed base and New Technology Penetration

血栓切除设备市场还为您提供每个国家/地区资本设备医疗支出增长、创伤设备市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗监管情景的变化及其对创伤设备市场的影响的详细市场分析。数据涵盖 2011-2021 年的历史时期。

竞争格局和全球血栓切除设备市场份额分析

血栓切除设备市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对血栓切除设备市场的关注有关。

血栓切除设备市场的一些主要参与者包括：

• 美敦力（爱尔兰）
• Inari Medical, Inc（美国）
• AngioDynamics（美国）
• 泰尔茂株式会社 (日本)
• 史赛克（美国）
• Zimmer Biomet（美国）
• 波士顿科学公司 (美国)
• BD（美国）
• Straub Medical AG（瑞士）
• Penumbra, Inc（美国）
• 爱德华生命科学公司（美国）
• ARGON MEDICAL。（美国）
• Teleflex Incorporated（美国）
• phenox GmbH (德国)
• Acandis GmbH (德国)
• Merit Medical Systems（美国）
• 拜耳公司（德国）
• Getinge AB（瑞典）
• 飞利浦医疗保健（美国）

SKU-23666